Annals of Oncology 18: 985–990, 2007
Published online 9 October 2006
Epidemiology of peritoneal mesothelioma: a review
International Agency for Research on Cancer, Lyon, France
Received 4 April 2006; revised 2 August 2006; accepted 18 August 2006
The epidemiology of peritoneal mesothelioma is complicated by possible geographic and temporal variations in
diagnostic practices. The incidence rates in industrialized countries range between 0.5 and three cases per
million in men and between 0.2 and two cases per million in women. Exposure to asbestos is the main known
cause of peritoneal mesothelioma. Results on peritoneal mesothelioma have been reported for 34 cohorts
exposed to asbestos, among which a strong correlation was present between the percentages of deaths from
pleural and peritoneal mesothelioma (correlation coefficient 0.8, P < 0.0001). Studies of workers exposed
only or predominantly to chrysotile asbestos resulted in a lower proportion of total deaths from peritoneal
mesothelioma than studies of workers exposed to amphibole or mixed type of asbestos. Cases of peritoneal
mesothelioma have also been reported following exposure to erionite and Thorotrast, providing further evidence
of common etiological factors with the pleural form of the disease. The role of other suspected risk factors, such
as simian virus 40 infection and genetic predisposition, is unclear at present. Control of asbestos exposure
remains the main approach to prevent peritoneal mesothelioma.
Key words: asbestos, epidemiology, peritoneal mesothelioma, thorotrast
The peritoneum is the second most frequent site of origin of
mesothelioma, after the pleura. In developed countries,
malignant mesothelioma (International Classification of Diseases
for Oncology–Morphology codes 9050–9055) is the most
frequent malignant neoplasm of the peritoneum . Symptoms
of peritoneal mesothelioma are unspecific, the most frequent
beingincreasedabdominal girth,painandweightloss ;usually
diagnosis occurs late. Treatment includes the combination of
debulking surgery and i.p. chemotherapy. Survival remains poor;
in the USA Surveillance, Epidemiology and End Results (SEER)
cancer registry data median survival is 10 months and relative
5-year survival is 16% , however, in selected clinical series
a longer survival (median >50 months) has been reported .
Although asbestos has been known for several decades to cause
peritoneal mesothelioma, in addition to the pleural form of the
disease , no detailed review of the epidemiological features of
this disease has been published recently.
The descriptive epidemiology of peritoneal mesothelioma is
complicated by temporal and geographic variability in
diagnostic criteria. In addition, low sensitivity and low
specificity of the diagnosis are important concerns, since
mesothelioma of the peritoneum can be misdiagnosed as
a neoplasm originating from other abdominal organs, notably
adenocarcinoma from the ovary, and vice versa [5, 6].
Furthermore, sensitivity and specificity of the diagnosis may
vary by place and time, thus complicating geographic and
temporal analyses of the occurrence of the disease. Furthermore,
given the strong association between asbestos and
mesothelioma, knowledge of previous exposure might
influence diagnostic accuracy; if this is the case, a diagnosis
of peritoneal mesothelioma would be more frequently made
for a patient with recognized past asbestos exposure than for
a patient with a similar clinical presentation but without
history of asbestos exposure.
The consequences of these potential biases are difficult to
assess. Although it is likely that occurrence of peritoneal
mesothelioma is underestimated in most populations,
overestimation might occur in circumstances of recognized
asbestos exposure. In general, caution should be used in the
interpretation of the available data on the incidence and
mortality from this disease.
Recent international data on the incidence of peritoneal
mesothelioma are available from Eurocim, a collaboration of
European population-based cancer registries , and from the
SEER program of the United States . Only sparse data are
available from the other countries. Figure 1 reports the most
recent data from selected nationwide European cancer registries
and the SEER registries; at this level of aggregation, age-
standardized incidence rates among men range from 0.5 to
about three cases per million population. However, higher rates
*Correspondence to: Dr P. Boffetta, International Agency for Research on Cancer,
150 Cours Albert Thomas, 69008 Lyon, France. Tel +33-4-72738554;
Fax: +33-4-72738320; E-mail: email@example.com
ª 2006 European Society for Medical Oncology
by guest on June 5, 2013
are reported in smaller areas with widespread past use of
asbestos, such as the harbor city of Genoa, Italy (age-
standardized rate in men in 1995, 5.5 per million). In most
populations, rates among women are in the range 0.2–2 per
million and are lower than in men; although in some countries,
such as Sweden, rates are comparable in the two sexes. A
correlation in incidence rates exists between the two sexes
(correlation coefficient of 1991–1995 rates on the basis of
41 European and nine USA populations covered by cancer
registry, 0.41; P = 0.003).
Figure 2 shows the temporal trend in peritoneal
mesothelioma incidence among men in selected countries [3, 7].
Rates between 1971 and 1995 remained stable in Sweden and
United States (SEER), while they have increased in countries
such as Denmark and Scotland. The analysis of age-specific
rates provides a deeper insight in the pattern of disease
incidence, but it is feasible only in populations with a large
enough number of cases to provide meaningful results. Figure 3
shows such rates in England during 1971–1995 (men only);
a birth cohort effect is indicated, with the highest rates
experienced by men born between 1920 and 1930. A decline
in the last time periods is apparent among young men,
indicating that the overall incidence might decline in the
future. Age- and time-specific trends in women cannot be
adequately studied because of random variability.
In an analysis of 50 European and USA populations [3, 7], the
incidence rates of peritoneal mesothelioma in men were one
order of magnitude lower than those of pleural mesothelioma.
Rates of peritoneal mesothelioma among men showed only
a modest correlation with that of the pleural form of the disease
(Figure 4). A comparable analysis among women resulted in an
even weaker correlation (correlation coefficient 0.14, P value
0.32). The modest correlation between peritoneal and pleural
mesothelioma rates can be explained by differences in risk
factors (e.g. circumstances of exposure to asbestos), but can also
derive from bias in diagnostic and registration procedures.
exposure to asbestos
Data on the occurrence of peritoneal mesothelioma have been
reported for 34 cohort studies of workers exposed to asbestos
and asbestosis patients. The characteristics and key results of
these cohorts are summarized in Table 1. A formal analysis of
observed versus expected deaths (or cases) was presented in only
few studies, because of difficulties in obtaining reliable reference
rates. In order to provide some comparison between the
cohorts, we used the proportion of peritoneal mesothelioma
deaths over the total number of death as a measure of risk.
This approach ignores differences in the age structure of the
different study populations as well as temporal changes in the
underlying rates. However, it is a relatively good indicator of
the effect of an important determinant of the disease.
No peritoneal mesothelioma deaths were reported in 14 of the
34 studies; only two of these studies, however, comprised >1000
deaths, thus providing a reasonable power to detect a risk [13,
33]. The proportion over total deaths ranged in most of the
remaining studies between 1/1000 and 1/100 (Table 1), with the
Figure 1. Incidence of peritoneal mesothelioma in selected countries
* 1973-1975 for US SEER
DenmarkEngland ScotlandSweden US SEER
Figure 2. Temporal trend in the incidence of peritoneal mesothelioma
in selected countries (men).
35-4445-54 55-64 65-74 75-84
Figure 3. Age- and calendar time-specific incidence rates of peritoneal
mesothelioma in England (men).
Figure 4. Correlation of peritoneal and pleural mesothelioma incidence
rates among men, 1991–1995 (41 European and nine surveillance,
epidemiology and end results populations).
Annals of Oncology
986 | BoffettaVolume 18| No. 6| June 2007
by guest on June 5, 2013
exception of cohorts of cement workers from Canada ,
insulators from United States  and asbestosis patients from
Italy  in which ‡4% of total deaths were from peritoneal
mesothelioma. There was a strong correlation between the
percentage of peritoneal mesothelioma deaths and both the
percentage of pleural mesothelioma deaths (Figure 5) and the
standardized mortality ratio of lung cancer (not shown in detail,
correlation coefficient 0.85, P < 0.0001). The latter result
replicates the finding of a previous analysis of a smaller number
of cohort studies .
A higher proportion of studies of cohorts of workers exposed
to chrysotile (either as unique or as predominant fiber type)
reported no peritoneal mesothelioma deaths (nine of 15) as
compared with studies of cohorts of workers to amphiboles or
mixed fibers (four of 17; Table 2, column 3; chi-square test, P
value 0.04). The proportion of mesothelioma deaths over total
deaths was higher in cohorts exposed to amphiboles or mixed
fibers than in cohorts exposed to chrysotile (Table 2), but the
difference was not statistically significant (P value after
correlation coefficient 0.80, p<0.0001
% pleural meso.
% perit. meso.
Figure 5. Correlation of percentage of pleural and peritoneal
mesothelioma deaths in cohorts of asbestos-exposed workers.
Table 1. Characteristics and results on peritoneal mesothelioma of cohorts of workers exposed to asbestos and of asbestosis patients
n Exposure circumstanceFiber type Country Period employment SexSize Evidence TD PlMD PeMD LC SMR Reference
1 Gas mask manufacture
2 Gas mask manufacture
3 Gas mask manufacture
4 Textile product manufacture
5 Cement workers
6 Cement workers
7 Friction product manufacture Ch
8 Insulation manufacture
9 Railroad repair workers
10 Textile product manufacture
11 Cement workers
12 Shipyard workers
13 Cement workers
14 Mixed exposure
15 Mixed exposure
16 Various product manufacture Am
17 Cement workers
18 Cement workers
19 Vermiculite miners
20 Mixed exposure
21 Crocidolite miners
22 Cement workers
23 Insulation workers
24 Shipyard workers
26 Railroad construction work
27 Textile product manufacture
29 Cement workers
30 Asbestosis patients
31 Cement workers
32 Various product manufacture Ch
33 Asbestosis patients
34 Cement workers
United States 1938–1958
United States 1939–1958
United States 1950–1969
United States 1941–1945
United States 1937–1970
United States 1970–1981
United States 1941–1967
United States 1967
United States 1940–1965
aPeriod of diagnosis.
Fiber type: Ch, pure chrysotile; P Ch, predominantly chrysotile; Cr, crocidolite (pure or predominant); Am, amosite (pure or predominant); Antho,
anthophillite; Tre-Act, tremolite-actinophyllite. Sex: M, males; F, females; MF, males and females; PM, predominantly males. Evidence: DC, death certificate;
CR, cancer registry; BE, best evidence (ad hoc investigation); MR, routine medical records. TD, total deaths; PlMD, pleural mesothelioma deaths; PeMD,
peritoneal mesothelioma deaths; LC SMR, standardized mortality ratio of lung cancer; NA, not available.
Annals of Oncology
Volume 18 | No. 6 | June 2007doi:10.1093/annonc/mdl345 | 987
by guest on June 5, 2013
adjustment for geographic region, 0.09). It was not possible to
assess the effect of different types of amphibole fibers. Similar
conclusions were noticed in a previous analysis of a smaller
number of cohorts . No effect of geographic region on the
proportion of mesothelioma deaths over total deaths was
detected [P value, on the basis of four regions (United States,
UK, Western Europe, other countries) and adjusted for asbestos
type, 0.9]. Only four studies were available of women (Table 1),
pre-empting detailed analyses. No difference was found in the
proportion of peritoneal mesothelioma deaths over total deaths
according to diagnostic accuracy (death certificate versus best
evidence, results not shown in detail). An effect of period of
employment was apparent, with the cohorts of workers first
employed before 1950 having a lower proportion of
peritoneal mesothelioma deaths over total deaths than
cohorts of workers employed later (P value after adjustment
for geographic region, 0.005). This finding might reflect
improved diagnostic accuracy during recent decades.
The dose–response relationship between occupational
asbestos exposure and peritoneal mesothelioma risk has been
investigated on the basis of the studies providing information
on quantitative asbestos exposure . The risk of peritoneal
mesothelioma for workers exposed to amphiboles was
proportional to the square of cumulative exposure, while
a similar estimate could not be obtained for chrysotile-exposed
workers [41, 42].
The important role of occupational exposure to asbestos in
causing peritoneal mesothelioma has been confirmed in two
community-based studies. A study from 24 of the United States
 included 657 death certificates with peritoneal cancer (not
specified as to histological type) as underlying cause recorded
during 1984–1992. The occupation listed on the death certificate
of these decedents (typically, the last occupation) was more
frequently a job-entailing exposure to asbestos than the
occupation of controls (deaths from other causes, matched
10 : 1 to cases). In particular, the odds ratio (OR) of peritoneal
cancer was 180 [95% confidence interval (CI) 23, 1375] for
insulation workers and 7.6 (95% CI 2.3, 25) for manufacturers
of nonmetallic mineral products, including asbestos. When the
authors applied a matrix for asbestos exposure on the basis of
the jobs listed on the death certificate, they found a strong
relationship with probability and intensity of exposure.
In a case–control study from Los Angeles and New York,
USA, 20 cases of (or deaths from) peritoneal mesothelioma
among men were compared with death certificate controls .
Interviews were conducted with next of kin. Exposure to
asbestos, either self-reported or derived from occupational
history, was present for 17 of the cases (OR 3.1, 95% CI 0.8, 15).
The fraction of peritoneal mesothelioma attributable to asbestos
exposure in this population was 58% (95% CI 20, 89).
Two studies provided evidence of an increased risk of
peritoneal mesothelioma following nonoccupational exposure
to asbestos. In a study from England, two cases of peritoneal
mesothelioma were reported in women with household
exposure . No cases were reported among individuals with
neighborhood exposure, while for sevencases, including three in
men, there was no evidence of occupational or environmental
exposure to asbestos. In a study from United States, eight cases
of peritoneal mesothelioma were reported among women
without occupational exposure; household exposure was
reported for seven of them and residential exposure for three,
including the case without household exposure . In the
case–control study from Los Angeles and New York mentioned
above, no cases of peritoneal mesothelioma had residential
exposure to asbestos .
exposure to other mineral fibers
Erionite is a silicate fiber belonging to the family of zeolites .
An increased risk of pleural mesothelioma and lung cancer has
been reported among residents in a contaminated area from
Cappadocia, Turkey, in which no sources of asbestos exposure
were identified [48–50]. In particular, in a survey of 141 deaths
in four villages, during 1979–1983, 29 deaths from pleural
mesothelioma (20.5%) and four deaths from peritoneal
mesothelioma (3.5%) were identified . In a study of 162
Cappadocian migrants to Sweden, one case of peritoneal
mesothelioma was identified .
There is no evidence of an increased risk of peritoneal
mesothelioma among workers exposed to man-made vitreous
fibers , although the available studies do not have
a sufficient statistical power to detect a small increase in risk.
Three cohorts of patients receiving Thorotrast for radiological
examinations reported results on peritoneal mesothelioma risk
(Table 3). Although a formal estimate of the risk is complicated
by uncertainties in the calculation of expected deaths, these
Table 2. Percentage of peritoneal mesothelioma deaths (PMDs) over total deaths (TDs), by type of asbestos fiber
Asbestos type Cohort number
(see Table 1)
n cohorts with
13 of 32
4 of 5
5 of 10
0 of 6
4 of 11
2, 7, 17, 22, 32
4, 5, 10, 11, 14, 18, 22, 24, 29, 34
1, 3, 8, 16, 21, 25
6, 9, 12, 13, 15, 20, 23, 26, 30, 31, 33
aInformation on proportion of PMD available for 30 cohorts (see Table 1 for details), excluding cohorts with no PMD.
Two cohorts (number 19 and 28) excluded from the analysis.
NA, not applicable.
Annals of Oncology
988 | Boffetta Volume 18| No. 6| June 2007
by guest on June 5, 2013
patients experienced a cumulative incidence of peritoneal
mesothelioma between 0.2% and 0.6%, higher than that of
many cohorts of asbestos-exposed workers listed in Table 1. The
incidence of peritoneal mesothelioma among Thorotrast
patients was comparable with, or even greater than, that of
pleural mesothelioma. The deposition of a-particles in
abdominal organs adjacent to the peritoneum, such as the liver,
spleen and lymph nodes is a plausible explanation of these
findings. The time of appearance of peritoneal mesotheliomas in
the Danish cohort of Thorotrast patients was longer than that of
other cancers whose risk was also increased, such as liver and
lung cancer . An additional three cohorts of Thorotrast
patients have been studied [56–58], but results for peritoneal
mesothelioma have not been reported. The evidence on the risk
of peritoneal mesothelioma following exposure to other sources
of ionizing radiation is limited to a few case reports, e.g. of
cancer patients who underwent radiotherapy .
other risk factors
A large number of studies detected sequences of the
papovavirus, simian virus 40 (SV40) in samples of pleural
mesothelioma ; however, the causal nature of this
association has been questioned , and laboratory
contamination may explain some of the findings . In one
of these studies, 11 German cases of peritoneal mesothelioma
were also included, seven of which were positive for SV40 Tag
A possible role of chronic pancreatitis in peritoneal
mesothelioma has been indicated, but not formally evaluated
. Genetic factors have been indicated to play a role in pleural
mesothelioma . Very limited information is available on the
peritoneal form of the disease. In the case–control study from
Los Angeles and New York mentioned above, the mother of an
asbestos-exposed case of peritoneal mesothelioma was reported
to have suffered from the same neoplasm . No studies are
available on other potential risk factors (e.g. nutrition).
The rarity of the peritoneal mesothelioma and its diagnostic
uncertainties limit our understanding of its epidemiological
features. Asbestos is the main known cause of the disease, but
other risk factors are likely to be involved in its etiology and
pathogenesis. Although the evidence is not conclusive, this
review of cohort and case–control studies indicates that the
association between asbestos exposure and peritoneal
mesothelioma is less strong than in the case of pleural
mesothelioma. This might explain the relatively low correlation
between the incidence of the two diseases. The other known risk
factors explain only a very small proportion of cases of
peritoneal mesothelioma. Despite these limitations, control of
exposure to asbestos, in particular at the workplace, remains the
main approach for the prevention of peritoneal mesothelioma.
1. Mack TM. Sarcomas and other malignancies of soft tissue, retroperitoneum,
peritoneum, pleura, heart, mediastinum, and spleen. Cancer 1995; 75: 211–244.
2. Mohamed F, Sugarbaker PH. Peritoneal mesothelioma. Curr Treat Options Oncol
2002; 3: 375–386.
3. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat
Database: Incidence—SEER 9 Regs Public-Use, Nov 2003 Sub (1973–2001),
National Cancer Institute, DCCPS, Surveillance Research Program, Cancer
Statistics Branch, released April 2004, based on the November 2003
submission; http://www.seer.cancer.gov (28 September 2006, date last
4. Wagner JC, Gilson JC, Berry G et al. Epidemiology of asbestos cancers. Br Med
Bull 1971; 27: 71–76.
5. Krasuski P, Poniecka A, Gal E. The diagnostic challenge of peritoneal
mesothelioma. Arch Gynecol Obstet 2002; 266: 130–132.
6. Nielsen AM, Olsen JH, Madsen PM et al. Peritoneal mesotheliomas in Danish
women: review of histopathologic slides and history of abdominal surgery. Acta
Obstet Gynecol Scand 1994; 73: 581–585.
7. European Network of Cancer Registries. Eurocim Version 4.0. European
Incidence Database V2.3, CI5 Dictionary (2001). Lyon, France: IARC 2001.
8. Jones JS, Smith PG, Pooley FD et al. The consequences of exposure to asbestos
dust in a wartime gas-mask factory. IARC Sci Publ 1980; 30: 637–653.
9. Acheson ED, Gardner MJ, Pippard EC et al. Mortality of two groups of women
who manufactured gas masks from chrysotile and crocidolite asbestos: a 40-year
follow-up. Br J Ind Med 1982; 39: 344–348.
10. McDonald AD, McDonald JC, Pooley FD. Mineral fibre content of lung in
mesothelial tumours in North America. Ann Occup Hyg 1982; 26: 417–422.
11. Thomas HF, Benjamin IT, Elwood PC et al. Further follow-up study of workers
from an asbestos cement factory. Br J Ind Med 1982; 39: 273–276.
12. Finkelstein MM. Mortality among employees of an Ontario asbestos-cement
factory. Am Rev Respir Dis 1984; 129: 754–761.
13. McDonald AD, Fry JS, Woolley AJ et al. Dust exposure and mortality in an
American chrysotile asbestos friction products plant. Br J Ind Med 1984; 41:
14. Acheson ED, Gardner MJ, Winter PD et al. Cancer in a factory using amosite
asbestos. Int J Epidemiol 1984; 13: 3–10.
15. Ohlson CG, Klaesson B, Hogstedt C. Mortality among asbestos-exposed workers
in a railroad workshop. Scand J Work Environ Health 1984; 10: 283–291.
16. Peto J, Doll R, Hermon C et al. Relationship of mortality to measures of
environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg
1985; 29: 305–355.
Table 3. Peritoneal mesothelioma in patients exposed to Thorotrast
n patientsn perit.
Denmark, cerebral arteriography1935–1992; CR99962 Pathological verification. p53 mutation
in peritoneal meso: 0 of 6
Germany, limb or cerebral
 Three additional retroperitoneal neoplasms
perit., peritoneal; meso, mesothelioma; pl., pleural; CR, cancer registry; AS, active surveillance; NR, not reported.
Annals of Oncology
Volume 18 | No. 6 | June 2007doi:10.1093/annonc/mdl345 | 989
by guest on June 5, 2013
17. Ohlson CG, Hogstedt C. Lung cancer among asbestos cement workers. A
Swedish cohort study and a review. Br J Ind Med 1985; 42: 397–402.
18. Kolonel LN, Yoshizawa CN, Hirohata T et al. Cancer occurrence in shipyard
workers exposed to asbestos in Hawaii. Cancer Res 1985; 45: 3924–3928.
19. Alies-Patin AM, Valleron AJ. Mortality of workers in a French asbestos cement
factory 1940–82. Br J Ind Med 1985; 42: 219–225.
20. Szeszenia-Dabrowska N, Wilczynska U, Szymczak W. Risk of cancer in women
occupationally exposed to asbestos dust. Med Pr 1986; 37: 243–249.
21. Woitowitz HJ, Lange HJ, Beierl L et al. Mortality rates in the Federal Republic of
Germany following previous occupational exposure to asbestos dust. Int Arch
Occup Environ Health 1986; 57: 161–171.
22. Seidman H, Selikoff IJ, Gelb SK. Mortality experience of amosite asbestos factory
workers: dose–response relationships 5 to 40 years after onset of short-term
work exposure. Am J Ind Med 1986; 10: 479–514.
23. Gardner MJ, Winter PD, Pannett B et al. Follow up study of workers
manufacturing chrysotile asbestos cement products. Br J Ind Med 1986; 43:
24. Hughes JM, Weill H, Hammad YY. Mortality of workers employed in two asbestos
cement manufacturing plants. Br J Ind Med 1987; 44: 161–174.
25. Amandus HE, Wheeler R. The morbidity and mortality of vermiculite miners and
millers exposed to tremolite-actinolite: part II. Mortality. Am J Ind Med 1987; 11:
26. Enterline PE, Hartley J, Henderson V. Asbestos and cancer: a cohort followed up
to death. Br J Ind Med 1987; 44: 396–401.
27. Armstrong BK, de Klerk NH, Musk AW et al. Mortality in miners and millers of
crocidolite in Western Australia. Br J Ind Med 1988; 45: 5–13.
28. Neuberger M, Kundi M. Individual asbestos exposure: smoking and mortality—a
cohort study in the asbestos cement industry. Br J Ind Med 1990; 47: 615–620.
29. Selikoff IJ, Seidman H. Asbestos-associated deaths among insulation workers in
the United States and Canada, 1967–1987. Ann N Y Acad Sci 1991; 643: 1–14.
30. Sanden A, Jarvholm B, Larsson S et al. The risk of lung cancer and
mesothelioma after cessation of asbestos exposure: a prospective cohort study of
shipyard workers. Eur Respir J 1992; 5: 281–285.
31. Sluis-Cremer GK, Liddell FD, Logan WP et al. The mortality of amphibole miners
in South Africa, 1946–80. Br J Ind Med 1992; 49: 566–575.
32. Menegozzo M, Belli S, Bruno C et al. Mortality due to causes correlatable to
asbestos in a cohort of workers in railway car construction. Med Lav 1993; 84:
33. Dement JM, Brown DP, Okun A. Follow-up study of chrysotile asbestos textile
workers: cohort mortality and case-control analyses. Am J Ind Med 1994; 26:
34. Meurman LO, Pukkala E, Hakama M. Incidence of cancer among anthophyllite
asbestos miners in Finland. Occup Environ Med 1994; 51: 421–425.
35. Magnani C, Terracini B, Ivaldi C et al. Tumor mortality and from other causes in
asbestos cement workers at the Casale Montferrato plant. Med Lav 1996; 87:
36. Germani D, Belli S, Bruno G et al. Cohort mortality study of women compensated
for asbestosis in Italy. Am J Ind Med 1999; 36: 129–134.
37. Tulchinsky TH, Ginsberg GM, Iscovich J et al. Cancer in ex-asbestos cement
workers in Israel, 1953–1992. Am J Ind Med 1999; 35: 1–8.
38. Yano E, Wang ZM, Wang XR et al. Cancer mortality among workers exposed to
amphibole-free chrysotile asbestos. Am J Epidemiol 2001; 154: 538–543.
39. Szeszenia-Dabrowska N, Urszula W, Szymczak W et al. Mortality study of workers
compensated for asbestosis in Poland, 1970–1997. Int J Occup Med Environ
Health 2002; 15: 267–278.
40. Ulvestad B, Kjaerheim K, Martinsen JI et al. Cancer incidence among workers in
the asbestos-cement producing industry in Norway. Scand J Work Environ Health
2002; 28: 411–417.
41. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer
in relation to asbestos exposure. Ann Occup Hyg 2000; 44: 565–601.
42. Coggon D, Inskip H, Winter P et al. Differences in occupational mortality from
pleural cancer, peritoneal cancer, and asbestosis. Occup Environ Med 1995; 52:
43. Cocco P, Dosemeci M. Peritoneal cancer and occupational exposure to asbestos:
results from the application of a job-exposure matrix. Am J Ind Med 1999; 35:
44. Spirtas R, Heineman EF, Bernstein L et al. Malignant mesothelioma: attributable
risk of asbestos exposure. Occup Environ Med 1994; 51: 804–811.
45. Newhouse ML, Thompson H. Mesothelioma of pleura and peritoneum following
exposure to asbestos in the London area. 1965. Br J Ind Med 1993; 50: 769–778.
46. Vianna NJ, Polan AK. Non-occupational exposure to asbestos and malignant
mesothelioma in females. Lancet 1978; i: 1061–1063.
47. International Agency for Research on Cancer. Silica and Some Silicates. IARC
Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans.
Volume 42. Lyon, France: IARC 1997; 225.
48. Baris YI, Saracci R, Simonato L et al. Malignant mesothelioma and radiological
chest abnormalities in two villages in Central Turkey. An epidemiological and
environmental investigation. Lancet 1981; i: 984–987.
49. Saracci R, Simonato L, Baris Y et al. The age-mortality curve of endemic pleural
mesothelioma in Karain, Central Turkey. Br J Cancer 1982; 45: 147–149.
50. Baris YI, Simonato L, Artvinli M et al. Epidemiological and environmental evidence
of the health effects of exposure to erionite fibres: a four-year study in the
Cappadocian region of Turkey. Int J Cancer 1987; 39: 10–17.
51. Metintas M, Hillerdal G, Metintas S. Malignant mesothelioma due to
environmental exposure to erionite: follow-up of a Turkish emigrant cohort. Eur
Respir J 1999; 13: 523–526.
52. International Agency for Research on Cancer. Man-Made Vitreous Fibres. IARC
Monographs on the Evaluation of The Carcinogenic Risks to Humans. Volume 81.
Lyon, France: IARC 2002.
53. Andersson M, Wallin H, Jonsson M et al. Lung carcinoma and malignant
mesothelioma in patients exposed to Thorotrast: incidence, histology and p53
status. Int J Cancer 1995; 63: 330–336.
54. Van Kaick G, Dalheimer A, Hornik S et al. The German thorotrast study: recent
results and assessment of risks. Radiat Res 1999; 152 (Suppl): S64–S71.
55. Ishikawa Y, Mori T, Machinami R. Lack of apparent excess of malignant
mesothelioma but increased overall malignancies of peritoneal cavity in Japanese
autopsies with Thorotrast injection into blood vessels. J Cancer Res Clin Oncol
1995; 121: 567–570.
56. Nyberg U, Nilsson B, Travis LB et al. Cancer incidence among Swedish patients
exposed to radioactive thorotrast: a forty-year follow-up survey. Radiat Res 2002;
57. Dos Santos Silva I, Malveiro F, Jones ME et al. Mortality after radiological
investigation with radioactive Thorotrast: a follow-up study of up to fifty years in
Portugal. Radiat Res 2003; 159: 521–534.
58. Travis LB, Hauptmann M, Gaul LK et al. Site-specific cancer incidence and
mortality after cerebral angiography with radioactive thortrast. Radiat Res 2003;
59. Gilks B, Hegedus C, Freeman H et al. Malignant peritoneal mesothelioma after
remote abdominal radiation. Cancer 1988; 61: 2019–2021.
60. Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or
causality? Nat Rev Cancer 2002; 2: 957–964.
61. Klein G, Powers A, Croce C. Association of SV40 with human tumors. Oncogene
2002; 21: 1141–1149.
62. Lo ´pez-Rı´os F, Illei BP, Rusch V et al. Evidence against a role for SV40 infection in
human mesotheliomas and high risk of false-positive PCR results owing to
presence of SV40 sequences in common laboratory plasmids. Lancet 2004; 364:
63. Shivapurkar N, Wiethege T, Wistuba II et al. Presence of simian virus 40
sequences in malignant pleural, peritoneal and noninvasive mesotheliomas. Int J
Cancer 2000; 85: 743–745.
64. Peterson JT Jr, Greenberg SD, Buffler PA. Non-asbestos-related malignant
mesothelioma. A review. Cancer 1984; 54: 951–960.
65. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin
Oncol 2002; 29: 2–17.
66. Heineman EF, Bernstein L, Stark AD et al. Mesothelioma, asbestos, and reported
history of cancer in first-degree relatives. Cancer 1996; 77: 549–554.
Annals of Oncology
990 | Boffetta Volume 18| No. 6| June 2007
by guest on June 5, 2013